JP3544493B2 - Nutrition composition for infants - Google Patents

Nutrition composition for infants Download PDF

Info

Publication number
JP3544493B2
JP3544493B2 JP16338399A JP16338399A JP3544493B2 JP 3544493 B2 JP3544493 B2 JP 3544493B2 JP 16338399 A JP16338399 A JP 16338399A JP 16338399 A JP16338399 A JP 16338399A JP 3544493 B2 JP3544493 B2 JP 3544493B2
Authority
JP
Japan
Prior art keywords
sphingomyelin
milk
infants
vitamin
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP16338399A
Other languages
Japanese (ja)
Other versions
JP2000350563A (en
Inventor
博昭 松山
睦美 元売
都 田中
如一 森田
誠一郎 青江
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Snow Brand Milk Products Co Ltd
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Priority to JP16338399A priority Critical patent/JP3544493B2/en
Publication of JP2000350563A publication Critical patent/JP2000350563A/en
Application granted granted Critical
Publication of JP3544493B2 publication Critical patent/JP3544493B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Description

【0001】
【発明の属する技術分野】
本発明は、スフィンゴミエリン又はスフィンゴミエリン含有リン脂質を配合した、消化管成熟促進作用を有する乳幼児用栄養組成物に関する。
本発明の栄養組成物を摂取することによって、消化管の成熟及び発達が促進され、消化吸収性の向上などの効果が得られる。
【0002】
【従来の技術】
最近、乳幼児用栄養組成物については、技術の向上により、究極の目標である成分的に母乳に相当に近似した製品が提供されている。しかし、機能面では未だ母乳に比べ多くの改良の余地が残されている。
一方、スフィンゴミエリンは、母乳中に多く含まれているにもかかわらず、その研究は細胞レべルにとどまっており、生体、特に乳幼児期における生理学的機能についての研究報告は数少ない。そのため、スフィンゴミエリンの栄養素の一成分としての有効性は認識されていなかった。また含量的にも、牛乳を主体とした栄養組成物、中でも育児用粉乳について、Zeiselらが報告した分析結果(J.Nutr.,vol.116,pp.50−58,1986 )から計算すると、母乳中の平均スフィンゴミエリン含量は0.0144%であるのに対し、調乳後の育児用粉乳で0.0018〜0.0071%と、半量以下しか含有していない。
なお、本発明における乳幼児用栄養組成物とは、乳児用に調製された調製乳、タンパク質分解乳、フォローアップミルク、特殊栄養調製乳、あるいは幼児用として調製された調製乳及び離乳食であって、これらは液状品、レトルト加工品、粉乳を含む乾燥品など形態を問わない。
【0003】
また、リン脂質の混合物であるレシチンは、天然の乳化剤として一般的に使用されているが、表1に示すように、代表的な大豆由来リン脂質にはスフィンゴミエリンは含まれていない。このようなことから、現在提供されている乳幼児用栄養組成物ではスフィンゴミエリンが十分供給されない。
【0004】
【表1】

Figure 0003544493
【0005】
【発明が解決しようとする課題】
上記状況に鑑み、本発明者らは、母乳中に含まれているスフィンゴミエリンが、乳幼児に対して何らかの生理学的効果を有するものであることを確信し、鋭意研究を重ねてきた。その結果、乳幼児の消化管成熟を促進する効果を有することを見出した。したがって、本発明品は、スフィンゴミエリンを配合あるいは強化することによって、消化管成熟促進作用を有する乳幼児用栄養組成物を提供することを課題とする。
【0006】
【課題を解決するための手段】
本発明では、消化管成熟を促進させる有効成分として、スフィンゴミエリンを乳幼児用栄養組成物に配合することを特徴とする。用いるスフィンゴミエリンは、精製したものでもよいし、スフィンゴミエリン含有リン脂質として使用してもよい。ただし、その原料は、表1に示したように、乳由釆であることが望ましく、生乳やホエータンパク質濃縮物(WPC)などを用いるのがよい。
生乳やホエータンパク質濃縮物(WPC)などからスフィンゴミエリンを得る方法としては、エーテルやアセトンで抽出する方法(特開平3−47192号公報)、バターを加温融解して得られるバターカードやバターセーラムを含む水溶性画分を用いる方法、バターミルクやバターセーラム中に含まれる乳脂肪球被膜画分を用いる方法などがあり、それぞれスフィンゴミエリン含有量は、約28%、約9%、約9%である。また、これらのスフィンゴミエリン含有リン脂質を透析、硫安分画、ゲル濾過、等電点沈殿、イオン交換クロマトグラフィー、溶媒分画などの手法により精製することによって純度を高めたスフィンゴミエリンを使用してもよい。これらのスフィンゴミエリンやスフィンゴミエリン含有リン脂質は、液体、粉体どちらの状態でも使用できる。
【0007】
本発明の乳幼児用栄養組成物とは、乳幼児用調製粉乳、低出生体重児用調製粉乳、フォローアップミルク、アレルギー疾患児用調製粉乳などであり、タンパク質、脂質、糖質、ビタミン類及びミネラル類を主成分として構成される。また、その他、乳幼児用栄養組成物に配合が可能な成分を加えてもよい。
タンパク質源としては、カゼイン、ホエータンパク質濃縮物(WPC)、ホエータンパク質分離物(WPI)、α−カゼイン、α−ラクトアルブミン、β−ラクトグロブリンなどの乳タンパク質分画物、あるいは大豆タンパク質や小麦タンパク質などの植物タンパク質、さらにはこれらのタンパク質を種々の分解度で酵素的に分解したペプチドやアミノ酸などを用いることができる。
脂質源としては、乳脂肪、ラード、牛脂やカツオ油、マグロ油などを含む魚油などの動物性油脂、あるいは大豆油、菜種油、コーン油、ヤシ油、パーム油、パーム核油、サフラワー油、エゴマ油、アマニ油、月見草油、中鎖脂肪酸トリグリセリド(MCT)、又は綿実油などの植物性油脂、さらにはこれらの油脂の分別油、水添油、エステル交換油などを用いることができる。
糖質源としては、乳糖、麦芽糖、ブドウ糖、ショ糖、デキストリンやガラクトシルラクトース、フラクトオリゴ糖、ラクチュロースなどのオリゴ糖、人工甘味料、可溶性多糖類、又は澱粉などを用いることができる。
【0008】
ビタミン及びミネラル源としては、「乳幼児食品を含む特殊用途食品の CODEX規格および関連衛生作業規則、CAC/VOL.IX−第1版およびSupplement 1,2,3,4」(日本国際酪農連盟発行, 1993年) 、「1993年版指定品目食品添加物便覧 (改訂第31版) 」 (食品と科学社発行, 1993年) 、又は「届け出制食品添加物・食品素材天然物便覧 (第12版) 」 (食品と科学社発行, 1992年) に記載のビタミン類及びミネラル類の中、乳幼児食品に使用が可能なものを用いることができる。例えば、ビタミン類としては、ビタミンA、ビタミンB、ビタミンC、ビタミンE、ビタミンK、葉酸、パントテン酸、β−カロチン、ニコチン酸アミドなどを挙げることができ、また、ミネラル類としては、カルシウム、マグネシウム、鉄、銅、亜鉛、ヨウ素、マンガン、セレンなどを挙げることができる。
また、乳幼児用栄養組成物にスフィンゴミエリンを配合して消化管成熟促進作用を発揮させるには、通常の栄養組成物の摂取量を考慮すると、組成物の固形100g当たりスフィンゴミエリンを0.05g以上含むようにすることが望ましいが、4.0gを越えて配合しても効果はさほど変わらない。
【0009】
【参考例1】
〈牛乳由来のスフィンゴミエリン含有リン脂質の調製〉
ホエータンパク質濃縮物(WPC)の10%水溶液にプロテアーゼを作用させて
得られた反応液をクロロホルム‐メタノール(2:1)溶液で抽出した後、濃縮し、さらにアセトン抽出して複合脂質画分を得た。次に、この複合脂質画分をフロロシリルカラムクロマトグラフィー処理し、クロロホルム‐メタノール溶液で段階抽出してリン脂質画分を得た。このリン脂質画分をシリカゲルクロマトグラフィー処理し、クロロホルム‐メタノール溶液で段階抽出して得られた画分を凍結乾燥してスフィンゴミエリン含有リン脂質を得た。
このスフィンゴミエリン含有リン脂質を薄層クロマトグラフィー処理した後、ディットマー試薬で発色し、デンシトメトリー法で測定したところ、スフィンゴミエリン含有率は95.2%であった。
【0010】
【実施例1】
<スフィンゴミエリンを用いた乳児用調製粉乳の製造>
脱脂乳24kgに、ホエータンパク質濃縮物(WPC)750gと、乳糖4.4kgを添加溶解し、これに水溶性ビタミン類(ビタミンB、ビタミンB、ビタミンB、ビタミンB12、ビタミンC、ナイアシン、葉酸、パントテン酸、ビオチン、コリン、イノシトール)と、ミネラル類(炭酸カルシウム、塩化カリウム、硫酸マグネシウム、クエン酸第一鉄ナトリウム、硫酸銅、硫酸亜鉛)をそれぞれ100g、スフィンゴミエリン10g、及び脂溶性ビタミン類(ビタミンA、ビタミンD、ビタミンE、ビタミンK、β‐カロチン)を溶解した調製脂肪2.39kgを混合して均質化した。得られた溶液を殺菌し、常法により濃縮・乾燥して、粉乳10kgを得た。
この粉乳を温水に溶解して固形率13%に調整した調製乳には、スフィンゴミエリン13mg/100mlが含まれていた。
【0011】
【実施例2】
<牛乳由来のスフィンゴミエリン含有脂質を用いた乳児用調製粉乳の製造>
脱脂乳24kgに、ホエータンパク質濃縮物(WPC)750gと、乳糖4.4kgを添加溶解し、これに水溶性ビタミン類(ビタミンB、ビタミンB、ビタミンB、ビタミンB12、ビタミンC、ナイアシン、葉酸、パントテン酸、ビオチン、コリン、イノシトール)と、ミネラル類(炭酸カルシウム、塩化カリウム、硫酸マグネシウム、クエン酸第一鉄ナトリウム、硫酸銅、硫酸亜鉛)をそれぞれ100g、参考例1で得られた牛乳由来のスフィンゴミエリン含有リン脂質50g、及び脂溶性ビタミン類(ビタミンA、ビタミンD、ビタミンE、ビタミンK、β‐カロチン)を溶解した調製脂肪2.0kgを混合して均質化した。得られた溶液を殺菌し、常法により濃縮・乾燥して、粉乳10kgを得た。
この粉乳を温水に溶解して固形率13%に調整した調製乳には、スフィンゴミエリン17.7mg/100mlが含まれていた。
【0012】
【試験例1】
<消化管成熟促進作用の確認試験>
哺乳期のS.D.系ラットを、ラット用に調製した人工乳を用いて人工哺育する実験を行なった。参考例1で得られた牛乳由来のスフィンゴミエリン含有リン脂質0.5%(w/v)を添加した人工乳(固形100g中のスフィンゴミエリン含量2.2g)を投与する群(添加群)と無添加人工乳を投与する群(無添加群)を設定し、7日齢のラットに胃カニュレーション手術を施した後、シリンジポンプで送乳しながら人工哺育した。人工哺育6日目に絶食し、7日目に解剖して小腸を摘出し、その重量と長さを計測した後、氷温下で小腸粘膜をカバーグラスで掻き取り、小腸粘膜酵素であるラクターゼ、マルターゼ及びスクラーゼの二糖類水解酵素活性とロイシンアミノペプチダーゼ(LAP)活性を測定した。小腸の重量と長さの計測値を表2に示す。
【0013】
【表2】
Figure 0003544493
【0014】
表3における小腸粘膜酵素の活性測定は以下の方法で行なった。
小腸粘膜を冷生理食塩水に懸濁後、ホモゲナイザーにて均質画分を調製した。この小腸粘膜の均質画分のタンパク質含量をLowry 法により測定した。
二糖類水解酵素活性の測定は、基質にラクトース、マルトース、スクロースを用い、基質溶液50μl、小腸粘膜の均質画分50μl を混合し、37℃、30分間インキュベートした。その反応液20μl について、グルコース測定用キット(和光純薬工業社製)を用い、酵素により分解され遊離したグルコース量を測定した。活性は、小腸粘膜の均質画分のタンパク質1gにより1分間に遊離するグルコース量(μmol )で示した。
ロイシンアミノペプチダーゼ(LAP)活性の測定は、ロイシンアミノペプチダーゼ(LAP)活性測定用キット(和光純薬工業社製)を用いた。
その結果は表3に示す。
なお、小腸の重量増加、小腸の伸張、ラクターゼ活性の低下、スクラーゼ活性、マルターゼ活性及びLAP活性の上昇を消化管成熟の指標とした。
【0015】
【表3】
Figure 0003544493
【0016】
表2から、添加群は無添加群に比べ、小腸の重量が増加し、小腸の長さが伸張していることが認められた。
また、表3に示すように、添加群のラクターゼ活性は低下し、スクラーゼ活性、マルターゼ活性及びLAP活性は上昇した。
【0017】
通常、哺乳後期にはラクターゼ活性は低下し、スクラーゼ活性及びマルターゼ活性は上昇する。これは、離乳が近づき、少しずつ乳以外の食物を摂取するようになることで、乳中の唯一の糖である乳糖の分解酵素ラクターゼの必要性が低下し、ショ糖や麦芽糖を分解するためのスクラーゼやマルターゼの必要性が増すからである。よってこれら二糖類水解酵素の活性は、哺乳期から離乳期にかけての小腸機能の変化を直に反映している。ロイシンアミノペプチダーゼ(LAP)活性は、タンパク質の終末消化に関与する酵素として、哺乳期から消化管の成熟とともに上昇していく。今回の実験で、ラクターゼ活性は低下し、スクラーゼ活性、マルターゼ活性及びLAP活性が上昇したことから、添加群は無添加群と比較して小腸の機能がより成熟化していることがわかった。
以上のことより、スフィンゴミエリンは消化管の成熟を促進していることが明らかとなった。
【0018】
【発明の効果】
本発明で用いるスフィンゴミエリン又はスフィンゴミエリン含有リン脂質は、消化管の成熟や発達を促進する作用を有し、消化吸収性の向上などの効果が顕著となるので、これらを含む組成物は、医薬あるいは食品として有用である。また、乳児用に調製された調製乳、タンパク質分解乳、フォロ一アップミルク、特殊栄養調製乳、あるいは幼児用として調製された離乳食として摂取することによって、乳幼児の消化管の成熟や発達が促進され、消化吸収性の向上などの効果を有するので、乳幼児用栄養組成物として特に有用である。[0001]
TECHNICAL FIELD OF THE INVENTION
TECHNICAL FIELD The present invention relates to a nutritional composition for infants having a digestive tract maturation promoting action, which comprises sphingomyelin or sphingomyelin-containing phospholipid.
By ingesting the nutritional composition of the present invention, the maturation and development of the digestive tract are promoted, and effects such as improvement in digestive absorption are obtained.
[0002]
[Prior art]
Recently, with respect to nutritional compositions for infants and infants, improvements in technology have provided products whose components are the ultimate goal, which are substantially similar to breast milk. However, there is still much room for improvement in function compared to breast milk.
On the other hand, sphingomyelin, despite its high content in breast milk, has been studied only at the cellular level, and few studies have been reported on physiological functions in living organisms, particularly in infancy. Therefore, the effectiveness of sphingomyelin as a nutrient component has not been recognized. In terms of the content, the nutritional composition mainly composed of milk, in particular, the powdered milk for childcare, is calculated from the analysis results (J. Nutr., Vol. 116, pp. 50-58, 1986) reported by Zeisel et al. The average content of sphingomyelin in breast milk is 0.0144%, whereas that of infant formula after preparation is 0.0018 to 0.0071%, which is less than half the content.
Incidentally, the nutritional composition for infants in the present invention is a formula prepared for infants, protein-decomposed milk, follow-up milk, special nutrition formula, or a formula and baby food prepared for infants, These may be in any form such as a liquid product, a retort-processed product, and a dried product containing milk powder.
[0003]
Lecithin, which is a mixture of phospholipids, is generally used as a natural emulsifier. However, as shown in Table 1, typical soybean-derived phospholipids do not contain sphingomyelin. For this reason, sphingomyelin is not sufficiently supplied in the currently provided nutritional composition for infants.
[0004]
[Table 1]
Figure 0003544493
[0005]
[Problems to be solved by the invention]
In view of the above situation, the present inventors have convinced that sphingomyelin contained in breast milk has some physiological effect on infants and have conducted intensive studies. As a result, they have found that they have an effect of promoting digestive tract maturation of infants. Therefore, an object of the present invention is to provide a nutritional composition for infants having a digestive tract maturation promoting action by blending or enhancing sphingomyelin.
[0006]
[Means for Solving the Problems]
The present invention is characterized in that sphingomyelin is added to a nutritional composition for infants as an active ingredient for promoting digestive tract maturation. The sphingomyelin used may be purified or used as a sphingomyelin-containing phospholipid. However, as shown in Table 1, the raw material is desirably milky, and raw milk or whey protein concentrate (WPC) is preferably used.
As a method for obtaining sphingomyelin from raw milk or whey protein concentrate (WPC), extraction with ether or acetone (JP-A-3-47192), butter curd or butter serum obtained by heating and melting butter are available. And a method using a milk fat globule-coated fraction contained in buttermilk or butter serum. The sphingomyelin content is about 28%, about 9%, or about 9%, respectively. It is. In addition, these sphingomyelin-containing phospholipids are purified by a method such as dialysis, ammonium sulfate fractionation, gel filtration, isoelectric point precipitation, ion exchange chromatography, and solvent fractionation, thereby using a sphingomyelin with increased purity. Is also good. These sphingomyelin and sphingomyelin-containing phospholipids can be used in either liquid or powder state.
[0007]
The nutritional composition for infants of the present invention includes infant formulas, infant formulas for low birth weight infants, follow-up milks, infant formulas for allergic diseases, etc., proteins, lipids, carbohydrates, vitamins and minerals. As a main component. In addition, you may add the component which can be mix | blended with the nutrition composition for infants.
Sources of protein, casein, whey protein concentrate (WPC), whey protein isolate (WPI), α S - casein, alpha-lactalbumin, milk protein fractions such as β- lactoglobulin, or soy protein and wheat Plant proteins such as proteins, and peptides and amino acids obtained by enzymatically decomposing these proteins at various degrees of degradation can be used.
As a lipid source, milk fat, lard, tallow oil, bonito oil, animal oils such as fish oil including tuna oil, or soybean oil, rapeseed oil, corn oil, coconut oil, palm oil, palm kernel oil, safflower oil, Vegetable oils such as perilla oil, linseed oil, evening primrose oil, medium-chain fatty acid triglyceride (MCT), and cottonseed oil, as well as fractionated oils, hydrogenated oils, and transesterified oils of these oils and fats can be used.
As a carbohydrate source, lactose, maltose, glucose, sucrose, dextrin, galactosyl lactose, fructooligosaccharides, oligosaccharides such as lactulose, artificial sweeteners, soluble polysaccharides, starch and the like can be used.
[0008]
Sources of vitamins and minerals include "CODEX Standards for Special Purpose Foods including Infant Foods and Related Hygiene Work Rules, CAC / VOL.IX-First Edition and Supplement 1,2,3,4" (published by the Japan International Dairy Federation, 1993), "Handbook of Designated Food Additives, 1993 Edition (Revised 31st Edition)" (Food and Science Co., Ltd., 1993), or "Handbook of Food Additives and Natural Food Products (12th Edition)" Among the vitamins and minerals described in (Food and Science Co., Ltd., 1992), those usable for infant foods can be used. For example, vitamins include vitamin A, vitamin B, vitamin C, vitamin E, vitamin K, folic acid, pantothenic acid, β-carotene, nicotinamide, and the like. Examples include magnesium, iron, copper, zinc, iodine, manganese, and selenium.
Moreover, in order to mix the sphingomyelin with the nutritional composition for infants and to exert the digestive tract maturation promoting action, in consideration of the usual intake of the nutritional composition, sphingomyelin is 0.05 g or more per 100 g of the solid of the composition. It is desirable to include it, but the effect does not change much even if it exceeds 4.0 g.
[0009]
[Reference Example 1]
<Preparation of sphingomyelin-containing phospholipids derived from milk>
A reaction solution obtained by allowing protease to act on a 10% aqueous solution of whey protein concentrate (WPC) is extracted with a chloroform-methanol (2: 1) solution, concentrated, and further extracted with acetone to separate a complex lipid fraction. Obtained. Next, this complex lipid fraction was subjected to fluorosilyl column chromatography and stepwise extracted with a chloroform-methanol solution to obtain a phospholipid fraction. The phospholipid fraction was subjected to silica gel chromatography, and the fraction obtained by stepwise extraction with a chloroform-methanol solution was freeze-dried to obtain a sphingomyelin-containing phospholipid.
After the sphingomyelin-containing phospholipid was subjected to thin-layer chromatography, the color was developed with a Dittmer reagent, and the sphingomyelin content was 95.2% as measured by densitometry.
[0010]
Embodiment 1
<Production of infant formula using sphingomyelin>
To 24 kg of skim milk, 750 g of whey protein concentrate (WPC) and 4.4 kg of lactose were added and dissolved, and water-soluble vitamins (vitamin B 1 , vitamin B 2 , vitamin B 6 , vitamin B 12 , vitamin C, Niacin, folic acid, pantothenic acid, biotin, choline, inositol) and minerals (calcium carbonate, potassium chloride, magnesium sulfate, ferrous sodium citrate, copper sulfate, zinc sulfate), 100 g each, sphingomyelin 10 g, and fat 2.39 kg of prepared fat in which soluble vitamins (vitamin A, vitamin D, vitamin E, vitamin K, β-carotene) were dissolved was mixed and homogenized. The obtained solution was sterilized, concentrated and dried by a conventional method to obtain 10 kg of milk powder.
The milk powder prepared by dissolving the milk powder in warm water to adjust the solid content to 13% contained sphingomyelin 13 mg / 100 ml.
[0011]
Embodiment 2
<Production of infant formula using milk-derived sphingomyelin-containing lipid>
To 24 kg of skim milk, 750 g of whey protein concentrate (WPC) and 4.4 kg of lactose were added and dissolved, and water-soluble vitamins (vitamin B 1 , vitamin B 2 , vitamin B 6 , vitamin B 12 , vitamin C, Niacin, folic acid, pantothenic acid, biotin, choline, inositol) and minerals (calcium carbonate, potassium chloride, magnesium sulfate, sodium ferrous citrate, copper sulfate, zinc sulfate), 100 g each, obtained in Reference Example 1. 50 g of sphingomyelin-containing phospholipids derived from milk, and 2.0 kg of a prepared fat in which fat-soluble vitamins (vitamin A, vitamin D, vitamin E, vitamin K, β-carotene) were dissolved, and homogenized. The obtained solution was sterilized, concentrated and dried by a conventional method to obtain 10 kg of milk powder.
The milk powder prepared by dissolving the milk powder in warm water to adjust the solid content to 13% contained sphingomyelin at 17.7 mg / 100 ml.
[0012]
[Test Example 1]
<Confirmation test for promoting digestive tract maturation>
S. in the suckling period D. An experiment was conducted in which the rats were artificially reared using artificial milk prepared for rats. A group (addition group) to which artificial milk (sphingomyelin content of 2.2 g in 100 g of solid) to which 0.5% (w / v) of sphingomyelin-containing phospholipid derived from milk obtained in Reference Example 1 is added; A group to which non-added artificial milk was administered (non-added group) was set, and a 7-day-old rat was subjected to gastric cannulation operation, and then artificially reared while feeding with a syringe pump. After fasting on the 6th day of artificial nursing, dissecting the small intestine on the 7th day, measuring its weight and length, scraping the small intestinal mucosa with a cover glass under ice temperature, and lactase, an enzyme of the small intestinal mucosa. , Maltase and sucrase disaccharide hydrolase activity and leucine aminopeptidase (LAP) activity were measured. Table 2 shows the measured values of the weight and length of the small intestine.
[0013]
[Table 2]
Figure 0003544493
[0014]
The activity of small intestinal mucosal enzymes in Table 3 was measured by the following method.
After the small intestinal mucosa was suspended in cold physiological saline, a homogenous fraction was prepared using a homogenizer. The protein content of the homogeneous fraction of the small intestinal mucosa was measured by the Lowry method.
For the measurement of disaccharide hydrolase activity, lactose, maltose, and sucrose were used as substrates, 50 μl of a substrate solution and 50 μl of a homogeneous fraction of small intestinal mucosa were mixed, and incubated at 37 ° C. for 30 minutes. Using a glucose measurement kit (manufactured by Wako Pure Chemical Industries, Ltd.), the amount of glucose released and decomposed by the enzyme was measured for 20 μl of the reaction solution. The activity was expressed as the amount of glucose (μmol) released per minute by 1 g of protein in the homogenous fraction of the small intestinal mucosa.
Leucine aminopeptidase (LAP) activity was measured using a leucine aminopeptidase (LAP) activity measurement kit (manufactured by Wako Pure Chemical Industries, Ltd.).
Table 3 shows the results.
The increase in the weight of the small intestine, the extension of the small intestine, the decrease in lactase activity, and the increase in sucrase activity, maltase activity and LAP activity were used as indices of digestive tract maturation.
[0015]
[Table 3]
Figure 0003544493
[0016]
From Table 2, it was confirmed that the weight of the small intestine was increased and the length of the small intestine was longer in the addition group than in the non-addition group.
Further, as shown in Table 3, the lactase activity of the added group decreased, and the sucrase activity, maltase activity and LAP activity increased.
[0017]
Normally, lactase activity decreases and sucrase activity and maltase activity increase during late suckling. This is due to the fact that weaning is approaching, and as we gradually ingest food other than milk, the need for lactase, the only sugar in milk, is reduced, which breaks down sucrose and maltose. This is because the need for sucrase and maltase increases. Thus, the activity of these disaccharide hydrolases directly reflects changes in small intestinal function from the suckling period to the weaning period. Leucine aminopeptidase (LAP) activity increases as the digestive tract matures from the suckling period as an enzyme involved in terminal digestion of proteins. In this experiment, the lactase activity decreased, and the sucrase activity, maltase activity, and LAP activity increased, indicating that the function of the small intestine was more mature in the added group than in the non-added group.
From the above, it was revealed that sphingomyelin promotes maturation of the digestive tract.
[0018]
【The invention's effect】
The sphingomyelin or sphingomyelin-containing phospholipid used in the present invention has an effect of promoting the maturation and development of the digestive tract, and has a remarkable effect such as an improvement in digestive absorption. Alternatively, it is useful as a food. In addition, by ingesting as infant formula, infant formula, protein-decomposed milk, follow-up milk, special nutrition formula, or baby food prepared for infants, maturation and development of the digestive tract of infants are promoted. It is particularly useful as a nutritional composition for infants because it has effects such as improvement in digestive and absorptive properties.

Claims (1)

組成物中に固形100g当たり0.05g〜4.0gのスフィンゴミエリンが含まれるようにスフィンゴミエリン又は乳由来のスフィンゴミエリン含有リン脂質を配合したことを特徴とする消化管成熟促進作用を有する乳幼児用栄養組成物。For infants having a digestive tract maturation promoting action, characterized in that sphingomyelin or a milk-derived sphingomyelin-containing phospholipid is blended so that the composition contains 0.05 to 4.0 g of sphingomyelin per 100 g of solid. Nutrition composition.
JP16338399A 1999-06-10 1999-06-10 Nutrition composition for infants Expired - Lifetime JP3544493B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP16338399A JP3544493B2 (en) 1999-06-10 1999-06-10 Nutrition composition for infants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16338399A JP3544493B2 (en) 1999-06-10 1999-06-10 Nutrition composition for infants

Publications (2)

Publication Number Publication Date
JP2000350563A JP2000350563A (en) 2000-12-19
JP3544493B2 true JP3544493B2 (en) 2004-07-21

Family

ID=15772855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16338399A Expired - Lifetime JP3544493B2 (en) 1999-06-10 1999-06-10 Nutrition composition for infants

Country Status (1)

Country Link
JP (1) JP3544493B2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120171177A1 (en) * 2009-06-02 2012-07-05 Nestec S.A. Nutritional composition for supporting brain development and function of toddlers

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1585508B1 (en) * 2003-01-20 2009-04-01 Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO Use of sphingolipids for reducing plasma cholesterol and triacylglycerol levels
NL1022442C2 (en) * 2003-01-20 2004-07-22 Tno Use of lipid to improve the absorption of nutrients and (pharmaceutically) active substances.
NL1022443C2 (en) 2003-01-20 2004-07-22 Tno Sphingolipids for improving the composition of the intestinal flora.
WO2005025333A1 (en) * 2003-09-18 2005-03-24 Arla Foods Amba Infant formula
TW200628075A (en) 2004-10-12 2006-08-16 Katrina Fletcher Dairy product and process
AU2005310341A1 (en) 2004-11-30 2006-06-08 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Sphingolipids in treatment and prevention of steatosis and of steatosis or of hepatotoxicity and its sequelae
WO2007073193A2 (en) * 2005-12-23 2007-06-28 N.V. Nutricia Infant nutritional compositions for preventing obesity
JP5208428B2 (en) * 2007-01-30 2013-06-12 雪印メグミルク株式会社 Skin care
JP5357005B2 (en) * 2007-02-21 2013-12-04 有限会社梅田事務所 Functional material manufacturing method, functional material and continuous heat treatment apparatus for obtaining the same
WO2009082216A1 (en) * 2007-12-21 2009-07-02 N.V. Nutricia Use of sphingomyelin and non-digestible carbohydrates for improving intestinal microbiota
EP2532351B1 (en) * 2010-02-03 2015-07-08 Kao Corporation Agent for improving motility function
JP6014493B2 (en) * 2012-12-28 2016-10-25 花王株式会社 Solid composition
CN110545679A (en) * 2017-05-03 2019-12-06 雀巢产品有限公司 Whey protein extract and its use as sphingomyelin source
CA3158010A1 (en) * 2019-10-29 2021-05-06 Aak Ab (Publ) Nutritional composition comprising milk and egg phospholipids
CN117378763B (en) * 2023-12-12 2024-03-26 内蒙古伊利实业集团股份有限公司 Nutritional composition with immunoregulatory function activity and application thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120171177A1 (en) * 2009-06-02 2012-07-05 Nestec S.A. Nutritional composition for supporting brain development and function of toddlers

Also Published As

Publication number Publication date
JP2000350563A (en) 2000-12-19

Similar Documents

Publication Publication Date Title
JP3544493B2 (en) Nutrition composition for infants
ES2597527T3 (en) Nutritional composition to promote healthy development and growth
Park Bioactive components in goat milk
JP3195594B2 (en) A food composition containing a milk-derived phospholipid.
JP3581010B2 (en) Lipid digestion and absorption function improver
RU2703177C2 (en) Infant nutrition with hydrolysed protein, ionic calcium and palmitic acid
JP4034370B2 (en) Brain function improving agent and nutritional composition
JPH1179987A (en) Composition for suppressing accumulation of hepatic fat and food additive for suppressing accumulation of hepatic fat
EP2037757B1 (en) Feed product for dairy cows and method of obtaining a dairy product
JP3920969B2 (en) Nutritional composition
JP2525624B2 (en) Baby milk powder containing polyunsaturated fatty acids
JP4679687B2 (en) Liver function improving agent
RU2703172C2 (en) Feeding for infants with hydrolysed protein and palmitic acid
KR101249082B1 (en) Infant formula containing hydrolyzed whey powder, hydrolyzed skin milk powder preparation and β-casein
JP3979543B2 (en) Antiallergic agent and method for producing the same
JPH10262607A (en) Nutrient composition for infant
JPH08259461A (en) Lipometabolism improver
IL305376A (en) Infant formulas containing human breast milk proteins
KR20130092768A (en) Goat milk infant formula comprising humanized protein composition for improved digestibility
JP3366769B2 (en) Nutritional composition containing milt
JP2009149550A (en) Lipid absorption promoter
JP4307475B2 (en) Infant nutrition composition
JP3903399B2 (en) Infant nutrition composition
JPS62224259A (en) Nourishing meal
JP2001029011A (en) Nutrient composition

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20031226

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040330

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040402

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 3544493

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090416

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090416

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100416

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110416

Year of fee payment: 7

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120416

Year of fee payment: 8

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120416

Year of fee payment: 8

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120416

Year of fee payment: 8

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120416

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130416

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130416

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140416

Year of fee payment: 10

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term